Relationship between constitutive nuclear factor-kappaB (NF-κB) and inhibitor kappaB-alpha (IκB-α) in an interferon-α-sensitive human Burkitt lymphoma cell line

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1741, Issue 3, 2005, Pages 253-263

  Rath, Pramod C ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

Burkitt lymphoma; Cell proliferation; Constitutive NF B; I B ; Interferon ; MAP kinase

Indexed keywords

ALPHA INTERFERON; I KAPPA B; I KAPPA B ALPHA; I KAPPA B BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN P53; THYMIDINE; TUMOR NECROSIS FACTOR ALPHA;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; BURKITT LYMPHOMA; CELL PROLIFERATION; CYTOTOXICITY; DAUDI CELL; DRUG TARGETING; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME PHOSPHORYLATION; HORMONE SENSITIVITY; HUMAN; HUMAN CELL; LYMPHOMA; LYMPHOMA CELL LINE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION;

APOPTOSIS; BLOTTING, WESTERN; BURKITT LYMPHOMA; CELL LINE, TUMOR; CELL PROLIFERATION; COLLAGEN TYPE XI; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; I-KAPPA B PROTEINS; INTERFERON-ALPHA; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; TETRAZOLIUM SALTS; THIAZOLES; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 25144522301     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2005.05.003     Document Type: Article

References (19)

1. R. Sen, and D. Baltimore Multiple nuclear factors interact with the immunoglobulin enhancer sequences Cell 47 1986 705 716
2. P.A. Baeuerle, and V.R. Baichwal NF-kappaB as a frequent target for immunosuppressive and anti-inflammatory molecules Adv. Immunol. 65 1997 111
3. A.A. Beg, and D. Baltimore An essential role for NF-kappaB in preventing TNF-alpha-induced cell death Science 274 1996 782 784
4. D.J. Van Antwerp, S.J. Martin, D.R. Green, and I.M. Verma Suppression of TNF-alpha-induced apoptosis by NF-kappaB Science 274 1996 787 789
5. C.Y. Wang, M.W. Mayo, and A.S. Baldwin Jr. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappa B Science 274 1996 784 787
6. B. Rayet, and C. Gelinas Aberrant rel/NF-kB genes activity in human cancer Oncogene 18 1999 6938 6947
7. Q. Li, and I.M. Verma NF-kappaB regulation in the immune system Nat. Rev., Immunol. 2 2002 725 734
8. A. Lin, and M. Karin NF-kappaB in cancer: a marked target Semin. Cancer Biol. 13 2003 107 114
9. M. Karin, Y. Yamamoto, and Q.M. Wang The IKK NF-kappaB system: a treasure trove for drug development Nat. Rev., Drug Discov. 3 2004 17 26
10. P.C. Rath, and B.B. Aggarwal Antiproliferative effects of IFN-α correlate with downregulation of nuclear factor kappa B (NF-κB) in human Burkitt lymphoma Daudi cells J. Interferon Cytokine Res. 21 2001 523 528
11. J. Sambrook, E.F. Fritsch, and T. Maniatis Molecular Cloning: A Laboratory Manual 1989 Cold Spring Harbor Laboratory Press New York
12. S.X. Hu, W. Ji, Y. Zhou, C. Logothetis, and H.J. Xu Development of an adenovirus vector with tetracycline-regulatable human tumor necrosis factor alpha gene expression Cancer Res. 57 1997 3339 3343
13. T.D. Gilmore, D. Kalaitzidis, M.C. Liang, and D.T. Starczynowski The c-Rel transcription factor and B-cell proliferation: a deal with the devil Oncogene 23 2004 2275 2286
14. A. Hoffmann, T.H. Leung, and D. Baltimore Genetic analysis of NF-kappaB/Rel transcription factors defines functional specificities EMBO J. 22 2003 5530 5539
15. T.H. Leung, A. Hoffmann, and D. Baltimore One nucleotide in a κB site can determine cofactor specificity for NF-κB dimers Cell 118 2004 453 464
16. A. Takaoka, S. Hayakawa, H. Yanai, D. Stoiber, H. Negishi, H. Kikuchi, S. Sasaki, K. Imal, T. Schibue, K. Honda, and T. Taniguchi Integration of interferon-α/β signaling to p53 responses in tumor suppression and antiviral defence Nature 424 2003 516 523
17. M.P. Thompson, B.B. Aggarwal, S. Shishodia, Z. Estrov, and R. Kurzrock Autocrine lymphotoxin production in Epstein-Barr virus-immortalized B cells: induction via NF-kappaB activation mediated by EBV-derived latent membrane protein 1 Leukemia 17 2003 2196 2201
18. M. Sanchez-Beato, A. Sanchez-Aguilera, and M.A. Piris Cell cycle deregulation in B-cell lymphomas Blood 101 2003 1220 1235
19. A. Richmond NF-kappa B, chemokine gene transcription and tumour growth Nat. Rev., Immunol. 2 2002 664 674